An interview with Dr. Anthony Fauci about the Covaxin vaccine makes you wonder why investors have any interest in Ocugen and OCGN stock. More
Articles
Dump Novavax Stock as Delays May Make Its Vaccine Practically Obsolete
Novavax's share price is down 41% year-to-date, bringing its six month decline to 63%, as the prospects of the biopharmaceutical company bringing a vaccine against Covid-19 to market grow dimmer by the hour. More
Fisker Has Positive News With Its Production Schedule On Track
Fisker has solid long term potential and if you can buy and hold FSR stock, now is a good time to take position. But you must have patience. More
Matterport Stock Isn’t the Buy It May Look Like as It Keeps Shedding Value
While the devastation caused by Matterport’s Q4 earnings may attract contrarians for MTTR stock, you might want to think twice. More
Even as Royal Caribbean Cruisers Return, It Remains More of a Trade
Royal Caribbean needs the world to return to normal by next year at the earliest. If it does, the cruise line and RCL stock holders can make a profit. More
The Russians Are All Too Happy to Give Shiba Inu a Reality Check
Although the metaverse should dominate discussions about Shiba Inu, geopolitical tensions provide a harsh gut check for SHIB. More
3 Excellent Energy Stocks to Buy as Oil Prices Soar
These energy stocks continue to outperform as the broader market weakens, driven by prices that are at their highest level in five years. More
